Skip to main content
OpenTrials
Completed

NCT Number: NCT06928194

Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.

The objective of this observational study is to determine whether the Kinovea video analysis tool is valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis, comparing the data obtained from this system with those of the gold standard, the GaitRite system. The main question to be answered is:

Is the Kinovea system valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis?

Participants walked across the GAITRite platform four times without shoes and four times with shoes, while being recorded by two cameras simultaneously: one recorded gait from the sagittal plane and the other from the frontal plane.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Gait Disorders, Neurologic Immune System Diseases Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

NeuroLab-Lázaro

Seville, Sevilla, 41015, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled for evaluation by the NeuroLab-Lázaro gait laboratory (Seville).
  • Patients who have signed informed consent prior to the test.
  • Patients between 18 and 55 years of age, diagnosed with MS according to the 2017 McDonald criteria.
  • Patients with an EDSS score of less than 6.5 points.
  • Patients who are willing to participate in the study and who do not object to being recorded while performing the gait test and to the use of images for educational and research purposes.

Exclusion criteria

  • Patients who use walking aids and/or orthoses.
  • Patients with comorbidity or decompensated systemic disease within the last month.
  • Patients who have any physical impediment (excessive fatigue) to performing the gait test, as documented in their medical records reviewed on the Diraya platform.
  • Patients who have suffered a relapse within 30 days prior to the start of the study.

Treatment and study plan

Primary outcomes

  1. Step length (cm)

    Time frame: With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

    Distance between the two heel strike points during initial contact of opposing feet.

  2. Stride length (cm)

    Time frame: With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

    Distance between the two heel strike points during initial contact of the same foot. Two step lengths add up to one stride length.

  3. Support base (cm)

    Time frame: With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

    Distance between the midpoints of the heels of two consecutive steps

  4. Cadence (steps/min)

    Time frame: With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

    Number of steps taken during a given period

  5. Walking speed (cm/s)

    Time frame: With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.

    Time taken to walk a known distance

Sponsors and collaborators

Lead sponsor

University of Cadiz

Other

Collaborators

  • Hospital Universitario Virgen Macarena

Registry information

Official study title

Reliability of the Kinovea System in the Study of Spatiotemporal Gait Parameters in Multiple Sclerosis: a Pilot Study.

Acronym: KV-MS

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 15, 2025
Registry last updated
Apr 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.